Thanks for visiting!

This project is now in update mode. Check back regularly to see how things are progressing.

Shining New Light on Alzheimer's Disease

$40,315
268%
Raised toward our $15,000 Goal
72 Donors
Project has ended
Project ended on May 03, at 11:59 PM CDT
Project Owners

A Generous “Matching" Gift from Mrs. June Waggoner Takes Us Way Beyond Expectations

May 06, 2015

Just after reaching our initial goal, Mrs. June Waggoner made a wonderful gift in honor of J. Virgil Waggoner that more than matched our fundraising target. We are truly honored by her generosity. Indeed, we are amazed at the incredible support we received from all of you who have a passion, like we do, for finding better ways to treat AD. With your collective help, we will be able to complete some critical animal studies as well as some lead optimization studies. As an optimist, I feel we are in a great position to make a difference and truly shine a new light on AD; as a realist I know much needs to be done, and the road ahead will be long with unanticipated detours and road blocks. So we make no promise other than to do our best to advance our discoveries. In that context, several companies may now be interested in our work. We will provide occasional updates to you, our loyal supporters, on the progress of our research. Stay tuned and Keep Your Horns Raised Against AD.

Exciting New Result!

April 13, 2015

We are now more than half way toward reaching our goal of $15,000: Thanks for your support!

We have one important result we want to share with you. Namely, a recent animal study shows that our lead compound does not appear to have any adverse effects in healthy mice when they are administered a dose 10-times greater than the dose we used to enhance cognition in AD mice. This significant finding shows that our candidate is well tolerated in animals.

We greatly appreciate your support that will help us shine a new light on AD. Keep your horns raised against AD!

Almost There-Thank You! Meet N' Greet on May 1st.

April 22, 2015

We are thrilled to announce that over $10,000 has been raised towards "Shining New Light on Alzheimer’s disease". Your generous donations have carried us 2/3rds of the way to our fundraising goal. We are in awe of the number of people who have gotten involved thus far, and we truly appreciate your support. About 10 days remain for us to raise the next $5000 so we can meet our goal. Please help us by telling your friends about our efforts and how they too can help us make progress to treat Alzheimer’s disease.

To say “Thank You” in person and to provide an opportunity to those of you who may live in the Austin area, there will be a Meet N’ Greet on May 1st at 4:00 PM. Belgium and craft beer will be on tap (donated by the non-profit organization, The Generalists) and snacks will be provided. Some of the research team will be on hand to share some of our work with you. This celebration will take place in a conference room behind Austin Beer Garden Brewing Co. (ABGB; 1305 W. Oltorf St, Austin, TX 78704). Please drive to the back of the parking lot and take a right; you will see a sign for the event. Parking will be much easier if you get there early. We look forward to meeting you!

Keep your Horns raised against AD!

Important Detail Regarding the Upcoming Meet N' Greet

April 22, 2015

Our apologies for another email, but we want to clarify an important detail about the "Meet N' Greet” we announced in the last update. No funds from donors will be used for this event. Rather, everything is being graciously provided by a generous, independent donation from The Generalists, a non-profit group that has been extremely supportive of our project. As a local, active non-profit group, they regularly host charitable events in Austin, such as The Love Beer Fundraiser, and they chose to further support our cause by hosting this get-together as a way to build further momentum for our research AND to show appreciation to our donors. We are grateful for their generous additional support.

Darrell K Royal Foundation Helps Us Reach Our Initial Goal

May 01, 2015

We are amazed and humbled by the generous gift received from the Darrell K Royal Foundation that enabled us to achieve our goal of $15,000. We are grateful to the Darrell K Royal Foundation and the rest of our donors for supporting our research towards developing a better way to treat Alzheimer's disease. Although we have reached our initial goal, we would like to raise  an additional $10,000 so we can advance our discoveries even closer to clinical trials. With this money, we will be able to expand our work and complete critical animal efficacy, pharmacokinetic, and toxicology studies needed for filing an Investigational New Drug Application with the FDA. Please continue your support of our efforts to Shine New Light on Alzheimer’s Disease by sharing our goals with your friends and loved ones.

Levels
Choose a giving level

$25

Bevo's Helper

Your contribution is a first step toward discovering a new approach for treating Alzheimer's disease

$50

Texas Longhorn

Your contribution will provide a day's worth of laboratory supplies that are needed to make new compounds for biological testing.

$100

1st and Ten

Your contribution will support one day of housing for 50 animals that will be used to test how well our compounds enhance congnition.

$250

Red Zone

This level of support will enable us to breed 5000 worms that will be used to test our compounds for neuroprotective activity.

$500

Touchdown

Your contribution will help fund animal studies that show how well our compounds are able to reach the brain.

$1,000

Shut Out

Your contribution will pay for the supplies needed to make five new compounds for biological testing.

$5,000

Game Changer

Your contribution will provide substantial support for critical behavioral studies to test the cognition enhancing effects of a new preclinical candidate.

$10,000

Royal Supporter

Your contribution will fully fund animal safety studies for a preclinical candidate.

$25,000

Angel Sponsor

Your generous contribution will support a study to assess the cognition-enhancing effects of one promising preclinical drug candidate in an Alzheimer's disease animal model.

Our Crowdfunding Groups